ロード中...
Peripheral endothelial dysfunction is a novel risk factor for systolic dysfunction and heart failure progression
BACKGROUND: ACC/AHA guidelines recognize the progressive nature of heart failure (HF). Patients with risk factors (Stage A) are at risk for developing asymptomatic cardiac dysfunction (Stage B), which may then lead to symptomatic HF (Stage C). As such, therapies targeting abnormalities in stages A a...
保存先:
| 出版年: | Int J Cardiol Heart Vasc |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7385446/ https://ncbi.nlm.nih.gov/pubmed/32743042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100584 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|